Clinical Trial

Cannabidiol After Multi-Trauma for Pain and Opioid Therapy

Study acronym: CAM-POT
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of this project is to investigate the therapeutic potential and safety of acute Cannabidiol (CBD) treatment on longitudinal pain symptoms, and to assess potential interactions with pain mediators including opioids and sex on CBD treatment response. To this end, this research protocol proposes a comprehensive translational approach including a placebo-controlled randomized clinical trial comparing two daily doses of CBD treatment administered for one month on pain relief. This study will also compare intervention conditions on inflammation markers, participant quality of life, sleep quality, depression, anxiety, cognition and orthopaedic function.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-06; most recent amendment 2025-07-28.
Status change: Not Yet Recruiting → Recruiting 2025-07-28
Trial Details
NCT Number NCT06448923
Lead Sponsor Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Conditions Fracture
Enrollment 225 participants
Start Date 2025-06-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-07-30